CADASIL Registry Study

NCT04310098 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-09-28

No results posted yet for this study

Summary

The aim of this study is to determine the clinical spectrum and natural progression of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and related disorders in a prospective multicenter study, to assess the clinical, genetic and epigenetic features of patients with CADASIL , to optimize clinical management.

Conditions

  • Cadasil

Sponsors & Collaborators

  • Bin Cai

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-09
Primary Completion
2039-03-09
Completion
2049-03-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04310098 on ClinicalTrials.gov